Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention
Tempus Ai,Inc.Tempus Ai,Inc.(US:TEM) ZACKS·2026-01-21 22:06

Key Takeaways Tempus AI reached over 1.1BinTCVandsigneddataagreementswithmorethan70pharmacustomers.TEMreportedpositiveadjustedEBITDAof1.1B in TCV and signed data agreements with more than 70 pharma customers. TEM reported positive adjusted EBITDA of 1.5M in Q3 2025, a 23.3Myear−over−yearimprovement.TempusAIsupportednearly1,500researchprojectsusingitsAIplatformacrossbiopharmaandproviders.TempusAI,Inc.(TEM)hasachievedseveralsignificantmilestonesoverthepastyear.ThecompanyrecordedTotalContractValue(“TCV”)ofmorethan23.3M year-over-year improvement. Tempus AI supported nearly 1,500 research projects using its AI platform across biopharma and providers. Tempus AI, Inc. (TEM) has achieved several significant milestones over the past year. The company recorded Total Contract Value (“TCV”) of more than 1.1 billion as of Dec. 31, 2025. It signed data ...